[/(
Regulatory/JJ
effect/NN
of/IN
insulin/NN
on/IN
glucocorticoid/NN
receptor/NN
in/IN
human/JJ
peripheral/JJ
leukocytes/NNS
]/)

The/DT
regulatory/JJ
effect/NN
of/IN
insulin/NN
on/IN
the/DT
specific/JJ
binding/VBG
power/NN
of/IN
glucocorticoid/NN
receptor/NN
(/(
GR/NN
)/)
of/IN
human/JJ
leukocytes/NNS
was/VBD
assessed/VBN
by/IN
the/DT
unoccupied/JJ
receptor/NN
sites/NNS
capable/JJ
of/IN
combining/VBG
with/IN
[3H]/NN
labelled/JJ
dexamethasone/NN
measured/VBN
at/IN
3/CD
and/CC
24/CD
h/NN
after/IN
incubation/NN
with/IN
various/JJ
concentrations/NNS
of/IN
insulin/NN
added/VBN
to/TO
the/DT
medium/NN
./.
=====
After/IN
3/CD
h/NN
incubation/NN
the/DT
specific/JJ
binding/VBG
power/NN
with/IN
[3H]/NN
Dex/NN
was/VBD
decreased/VBN
by/IN
23.3/CD
+/-/CC
10.0/CD
,/,
32.2/CD
+/-/CC
13.2/CD
and/CC
54.3/CD
+/-/CC
9.2/CD
%/NN
(/(
P/NN
greater/JJR
than/IN
0.05/CD
,/,
P/NN
greater/JJR
than/IN
0.05/CD
and/CC
P/NN
less/JJR
than/IN
0.01/CD
as/IN
compared/VBN
with/IN
the/DT
control/NN
value/NN
of/IN
100/CD
in/IN
the/DT
absence/NN
of/IN
insulin/NN
)/)
respectively/RB
in/IN
the/DT
presence/NN
of/IN
20/CD
mU/L/NN
(/(
physiological/JJ
testing/NN
concentration/NN
)/)
,/,
200/CD
mU/L/NN
(/(
physiological/JJ
upper/JJ
limit/NN
)/)
and/CC
2,000/CD
mU/L/NN
(/(
pharmacological/JJ
concentration/NN
)/)
insulin/NN
in/IN
the/DT
incubation/NN
medium/NN
./.
=====
After/IN
24/CD
h/NN
incubation/NN
the/DT
decrease/NN
of/IN
these/DT
values/NNS
increased/VBD
respectively/RB
to/TO
43.5/CD
+/-/CC
19.0/CD
,/,
56.1/CD
+/-/CC
20.7/CD
and/CC
80.2/CD
+/-/CC
15.5/CD
(/(
P/NN
less/JJR
than/IN
0.05/CD
,/,
P/NN
less/JJR
than/IN
0.01/CD
and/CC
P/NN
less/JJR
than/IN
0.01/CD
compared/VBN
with/IN
control/NN
)/)
./.
=====
Thus/RB
the/DT
inhibitory/JJ
effect/NN
of/IN
insulin/NN
on/IN
the/DT
GR/NN
binding/NN
power/NN
is/VBZ
both/CC
dose-/NN
and/CC
time-dependent/JJ
,/,
which/WDT
strongly/RB
suggests/VBZ
that/IN
GR/NN
is/VBZ
tonically/RB
controlled/VBN
by/IN
insulin/NN
concentration/NN
change/NN
under/IN
physiological/JJ
conditions/NNS
./.